Denosumab in Combination With Enzalutamide in Progressive Metastatic Castrate-resistant Prostate Cancer and Bone Metastases.

Clinical trial NCT03869762 · TERMINATED

Trial details

NCT number: NCT03869762
Sponsor: Cancer Trials Ireland
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Castration-resistant Prostate Cancer Metastatic Cancer Bone Metastases

Start date: 2019-01-09
Primary completion: 2019-01-12
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.